In bone marrow tumor DNA samples, the detection rate of BRAF V600Mx mutations was 4/83 (5%), KRAS Mx was 13/83 (16%), NRAS G12/G13 was 3/83 (4%) and NRAS Q61 was 14/83 (17%), which were approximately equivalent to those found using an NGS method. This evidence concerns the gene NRAS and neoplasm.